These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29437013)

  • 1. A Probable Topiramate-Induced Limbs Paraesthesia and Rigid Fingers Flexion.
    Pratico AD; Ruggieri M; Falsaperla R; Pavone P
    Curr Drug Saf; 2018; 13(2):131-136. PubMed ID: 29437013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients.
    Sedighi B; Shafiei K; Azizpour I
    Neurol Sci; 2016 Apr; 37(4):585-9. PubMed ID: 26809953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.
    Lo YL; Lum SY; Fook-Chong S; Siow HC
    J Headache Pain; 2010 Apr; 11(2):175-8. PubMed ID: 20143246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible hypohidrosis with topiramate therapy for chronic migraine.
    Markowitz SY; Robbins MS; Cascella C; Sheikh HU; Grosberg BM
    Headache; 2010 Apr; 50(4):672-4. PubMed ID: 20236344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypohidrosis induced by topiramate in an adult patient.
    Karachristianou S; Papamichalis E; Sarantopoulos A; Boura P; Georgiadis G
    Epileptic Disord; 2013 Jun; 15(2):203-6. PubMed ID: 23773932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic migraine prevention with topiramate.
    Peres MF; Mercante JP; Tanuri FC; Nunes M; Zukerman E
    J Headache Pain; 2006 Sep; 7(4):185-7. PubMed ID: 17016684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction.
    Galicia SC; Lewis SL; Metman LV
    Clin Neuropharmacol; 2005; 28(2):94-5. PubMed ID: 15795554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypohidrosis during topiramate treatment: a rare and reversible side effect.
    Cerminara C; Seri S; Bombardieri R; Pinci M; Curatolo P
    Pediatr Neurol; 2006 May; 34(5):392-4. PubMed ID: 16648001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
    Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
    Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topiramate on attention.
    Burton LA; Harden C
    Epilepsy Res; 1997 Apr; 27(1):29-32. PubMed ID: 9169288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate and metabolic acidosis: a case series and review of the literature.
    Groeper K; McCann ME
    Paediatr Anaesth; 2005 Feb; 15(2):167-70. PubMed ID: 15675937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topiramate in monotherapy or in combination as a cause of metabolic acidosis in adults with epilepsy].
    Ruiz-Granados VJ; Márquez-Romero JM
    Rev Neurol; 2015 Feb; 60(4):159-63. PubMed ID: 25670045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.